NCT01838174 arm group 0a903636d21ebba776e590d4e13e8416 [clinicaltrials_resource:NCT01838174/arm-group/0a903636d21ebba776e590d4e13e8416]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01838174 arm group 0a903636d21ebba776e590d4e13e8416 [clinicaltrials_resource:NCT01838174/arm-group/0a903636d21ebba776e590d4e13e8416]
Bio2RDF identifier
NCT01838174/arm-group/0a903636d21ebba776e590d4e13e8416
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 903636d21ebba776e590d4e13e8416
description [clinicaltrials_vocabulary:description]
3 days of IV methylprednisolone followed by 11 days of oral prednisone
identifier
clinicaltrials_resource:NCT01838174/arm-group/0a903636d21ebba776e590d4e13e8416
title
NCT01838174 arm group 0a903636d21ebba776e590d4e13e8416
@en
type
label
NCT01838174 arm group 0a903636 ...... 03636d21ebba776e590d4e13e8416]
@en